➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Boehringer Ingelheim
McKesson
Baxter
Colorcon

Last Updated: July 9, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Ispinesib


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Ispinesib?

Ispinesib is an investigational drug.

There have been 15 clinical trials for Ispinesib. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2005.

The most common disease conditions in clinical trials are Precursor Cell Lymphoblastic Leukemia-Lymphoma, Burkitt Lymphoma, and Lymphoma, Extranodal NK-T-Cell. The leading clinical trial sponsors are National Cancer Institute (NCI), GlaxoSmithKline, and NCIC Clinical Trials Group.

Recent Clinical Trials for Ispinesib
TitleSponsorPhase
A Study of Ispinesib in Metastatic Breast CancerCytokineticsPhase 1/Phase 2
Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1
Ispinesib in Treating Patients With Metastatic or Unresectable Kidney CancerNational Cancer Institute (NCI)Phase 2

See all Ispinesib clinical trials

Clinical Trial Summary for Ispinesib

Top disease conditions for Ispinesib
Top clinical trial sponsors for Ispinesib

See all Ispinesib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Moodys
McKesson
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.